CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
23 hedge funds and large institutions have $1.66M invested in Carisma Therapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
95% less capital invested
Capital invested by funds: $33.7M → $1.66M (-$32M)
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$705K | |
| 2 | +$77.8K | |
| 3 | +$21.6K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$16.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.71K |
Top Sellers
| 1 | -$8.62M | |
| 2 | -$6.97M | |
| 3 | -$2.64M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.33M |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$338K |